Biology of metastatic disease

Seminars in Thoracic and Cardiovascular Surgery

Volumn 14, Issue 1, 2002, Pages 10-17

  Pass, Harvey I ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Angiogenesis; Cytokines; Matrix metalloproteinases; Metastasis; Molecular biology

Indexed keywords

ANTINEOPLASTIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; CETUXIMAB; CYTOTOXIC AGENT; ENDOSTATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; GELATINASE A; GELATINASE B; MARIMASTAT; PLATINUM; THALIDOMIDE; VASCULOTROPIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; ARTICLE; BLOOD VESSEL; CANCER INVASION; CELL ADHESION; CELL TRANSPORT; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEAD AND NECK CANCER; HOST; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; METASTASIS; MOLECULAR BIOLOGY; MULTIPLE MYELOMA; MYALGIA; OVARY CANCER; PROSTATE CANCER; TUMOR GROWTH;

EID: 0036256251     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/stcs.2002.29534     Document Type: Article

References (51)

1. The distribution of secondary growth in cancer of the breast
2. Tumor and host molecules important in the organ preference of metastasis
3. Analysis of organ-specific effects on metastatic tumor formation by studies in vitro
4. Molecular basis of tumor progression: Mechanisms of organ-specific tumor metastasis
5. Clonal growth of tumors on tissue-specific biomatrices and correlation with organ site specificity of metastases
6. Regulatory pathways in tumor growth and invasion
7. Heparan sulfate and heparin as a potentiator or a suppressor of growth of normal and transformed vascular endothelial cells
8. Angiogenesis in cancer, vascular, rheumatoid and other disease
9. The role of cancer cell motility in invasion
10. Tumor invasion and metastasis: An imbalance of positive and negative regulation
11. Immunologically-mediated restraint of latent tumour metastases
12. Barrier function of lymph node to tumor cells and erythrocytes. I. Normal nodes
13. Role of plasma, platelets, and endothelial cells in tumor metastasis
14. Molecular determinants of angiogenesis in cancer metastasis
15. Cytokines in tumour growth, migration and metastasis
16. Lymphoreticular infiltration in human tumours: Prognostic and biological implications: A review
17. Tumor-associated macrophages in neoplastic progression: A paradigm for the in vivo function of chemokines
18. Cytokine regulation of metalloproteinase gene expression
19. Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: Endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1
20. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells
21. Immune mechanisms in the sequential steps of metastasis
22. Genetic control of cancer metastasis
23. Metalloproteinases and cancer invasion
24. Angiogenesis and breast cancer metastasis
25. Tumor angiogenesis in advanced stage ovarian carcinoma
26. Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma
27. Intratumor microvessel density as a prognostic factor in cancer
28. Angiogenesis and metastasis
29. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture
30. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
31. Biology of tumor micrometastasis
32. Effects of mast cell-macrophage interactions on the production of collagenolytic enzymes by metastatic tumor cells and tumor-derived and stromal fibroblasts
33. Macrophage and lymphocyte potentiation of syngeneic tumor cell and host fibroblast collagenolytic activity in rats
34. Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy
35. Motility and adhesive properties of high- and low-metastatic murine neoplastic cells
36. Gene expression, cellular diversification and tumor progression to the metastatic phenotype
37. The interrelationship of hematogenous and lymphatic tumor cell dissemination: An experimental study
38. Prostaglandins and gangliosides of tumor microenvironment: Their role in angiogenesis
39. Metastasis: Quantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2′-deoxyuridine
40. Nitric oxide synthases: Roles, tolls, and controls
41. The regulatory role of nitric oxide in apoptosis
42. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells
43. Tumor cell interactions with the extracellular matrix during invasion and metastasis
44. Cellular interactions in metastasis
45. Metastasis of metastases
46. Antiangiogenic strategies and agents in clinical trials
47. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
48. Thalidomide in cancer: Potential uses and limitations
49. Marimastat: The clinical development of a matrix metalloproteinase inhibitor
50. The EGF receptor family as targets for cancer therapy
51. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor